Income Statement Marker Therapeutics, Inc.

Equities

MRKR

US57055L2060

Biotechnology & Medical Research

Market Closed - Nasdaq Other stock markets 20:00:00 11/03/2026 GMT			5-day change	1st Jan Change
1.370 ^USD	-2.84%		0.00%	-8.05%

11-14	Marker Therapeutics Q3 net loss narrows to $2 mln	RE
11-13	Marker Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025	CI

725daecd6c2495c.DqSWuO95hHsXSNEBGdLM9dREp7GY-TpUelQSKKdHJyI.SsD7ydksyQFDOOZVTJeWrb0O5MSvqw0dEz1hYsIsQHp00uyKrVTpHFl85Q

Published financial data: MARKER THERAPEUTICS, INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2020	2021	2022	2023	2024
Revenues	467K	1.24M	9.01M	3.31M	6.59M
Total Revenues	467K	1.24M	9.01M	3.31M	6.59M
Cost of Goods Sold, Total	18.88M	27.79M	26.14M	10.42M	13.47M
Gross Profit	-18.41M	-26.55M	-17.13M	-7.11M	-6.88M
Selling General & Admin Expenses, Total	10.47M	12.92M	12.82M	7.48M	4.24M
R&D Expenses	-	-	-	-	-
Other Operating Expenses, Total	10.47M	12.92M	12.82M	7.48M	4.24M
Operating Income	-28.89M	-39.48M	-29.95M	-14.58M	-11.12M
Interest Expense, Total	-	-	-	-	-
Interest And Investment Income	149K	5.7K	248K	539K	437K
Net Interest Expenses	149K	5.7K	248K	539K	437K
Currency Exchange Gains (Loss)	-	-	-	-	-
Other Non Operating Income (Expenses)	31K	-	-	-	-
EBT, Excl. Unusual Items	-28.71M	-39.47M	-29.7M	-14.04M	-10.68M
Merger & Related Restructuring Charges	-	-	-	-	-
Other Unusual Items	-	-2.41M	-233K	-	-
EBT, Incl. Unusual Items	-28.71M	-41.88M	-29.93M	-14.04M	-10.68M
Income Tax Expense	-	-	-	3.68K	49.95K
Earnings From Continuing Operations	-28.71M	-41.88M	-29.93M	-14.05M	-10.73M
Earnings Of Discontinued Operations	-	-	-	5.81M	-
Net Income to Company	-28.71M	-41.88M	-29.93M	-8.24M	-10.73M
Net Income - (IS)	-28.71M	-41.88M	-29.93M	-8.24M	-10.73M
Net Income to Common Incl Extra Items	-28.71M	-41.88M	-29.93M	-8.24M	-10.73M
Net Income to Common Excl. Extra Items	-28.71M	-41.88M	-29.93M	-14.05M	-10.73M
Per Share Items
Net EPS - Basic	-6.1	-5.47	-3.58	-0.94	-1.19
Basic EPS - Continuing Operations	-6.1	-5.47	-3.58	-1.59	-1.19
Basic Weighted Average Shares Outstanding	4.7M	7.65M	8.35M	8.81M	8.98M
Net EPS - Diluted	-6.1	-5.5	-3.58	-0.94	-1.19
Diluted EPS - Continuing Operations	-6.1	-5.5	-3.58	-1.59	-1.19
Diluted Weighted Average Shares Outstanding	4.7M	7.65M	8.35M	8.81M	8.98M
Normalized Basic EPS	-3.81	-3.22	-2.22	-1	-0.74
Normalized Diluted EPS	-3.81	-3.22	-2.22	-1	-0.74
Supplemental Items
EBITDA	-28.4M	-37.33M	-27.16M	-11.79M	-
EBITA	-28.89M	-39.48M	-29.95M	-14.58M	-11.12M
EBIT	-28.89M	-39.48M	-29.95M	-14.58M	-11.12M
EBITDAR	-27.25M	-35.02M	-24.98M	-	-
Total Revenues (As Reported)	467K	1.24M	9.01M	3.31M	6.59M
Effective Tax Rate - (Ratio)	-	-	-	-0.03	-0.47
Normalized Net Income	-17.94M	-24.67M	-18.56M	-8.78M	-6.68M
Supplemental Operating Expense Items
General and Administrative Expenses	10.47M	12.92M	12.82M	7.48M	4.24M
Research And Development Expense From Footnotes	18.88M	27.79M	26.14M	10.42M	13.47M
Net Rental Expense, Total	1.15M	2.31M	2.18M	-	-
Stock-Based Comp., COGS (Total)	2.59M	2.86M	2.69M	338K	15K
Stock-Based Comp., R&D Exp. (Total)	-	-	-	-	-
Stock-Based Comp., G&A Exp. (Total)	2.64M	3.11M	2.65M	520K	231K
Stock-Based Comp., Other (Total)	409	48	6	269	-
Total Stock-Based Compensation	5.23M	5.96M	5.34M	858K	246K

Fiscal Period: December	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	21.35M	42.35M	11.78M	15.11M	19.19M
Total Cash And Short Term Investments	21.35M	42.35M	11.78M	15.11M	19.19M
Other Receivables	1M	237	2.4M	1.03M	2.35M
Total Receivables	1M	237	2.4M	1.03M	2.35M
Prepaid Expenses	2.06M	2.48M	2.44M	988K	484K
Restricted Cash	-	1.15M	-	-	-
Total Current Assets	24.41M	45.98M	16.62M	17.13M	22.02M
Gross Property Plant And Equipment	21.79M	24.89M	23.08M	-	-
Accumulated Depreciation	-591K	-2.74M	-5.27M	-	-
Net Property Plant And Equipment	21.2M	22.15M	17.8M	-	-
Total Assets	45.61M	68.14M	34.42M	17.13M	22.02M
Liabilities
Accounts Payable, Total	2.94M	5.14M	1.61M	961K	1.07M
Accrued Expenses, Total	2.67M	3.33M	2.68M	1.91M	2.19M
Short-term Borrowings	-	-	-	-	-
Current Portion of Leases	389K	620K	577K	-	-
Unearned Revenue Current, Total	-	1.15M	2.5M	-	-
Other Current Liabilities	404K	2.66M	414K	205K	205K
Total Current Liabilities	6.4M	12.9M	7.78M	3.07M	3.46M
Long-Term Leases	11.87M	11.25M	7.04M	-	-
Total Liabilities	18.27M	24.15M	14.82M	3.07M	3.46M
Common Stock, Total	50.73K	83.08K	8.41K	8.89K	10.71K
Additional Paid In Capital	384M	442M	448M	450M	466M
Retained Earnings	-356M	-398M	-428M	-436M	-447M
Total Common Equity	27.34M	43.99M	19.6M	14.05M	18.56M
Total Equity	27.34M	43.99M	19.6M	14.05M	18.56M
Total Liabilities And Equity	45.61M	68.14M	34.42M	17.13M	22.02M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	5.07M	8.31M	8.8M	8.9M	10.71M
ECS Total Common Shares Outstanding	5.07M	8.31M	8.41M	8.89M	10.71M
Book Value / Share	5.39	5.29	2.33	1.58	1.73
Tangible Book Value	27.34M	43.99M	19.6M	14.05M	18.56M
Tangible Book Value Per Share	5.39	5.29	2.33	1.58	1.73
Total Debt	12.26M	11.87M	7.62M	0	0
Net Debt	-9.1M	-30.48M	-4.17M	-15.11M	-19.19M
Debt Equivalent Oper. Leases	9.19M	18.46M	17.43M	-	-
Account Code - Inventory Valuation	3	3	3	3	3
Machinery, Total	3.87M	9.66M	13.65M	-	-
Full Time Employees	44	56	67	8	5

Fiscal Period: December	2020	2021	2022	2023	2024
Net Income	-28.71M	-41.88M	-29.93M	-8.24M	-10.73M
Depreciation & Amortization - CF	1.08M	3.16M	3.68M	-	-
Depreciation & Amortization, Total	1.08M	3.16M	3.68M	-	-
(Gain) Loss From Sale Of Asset	-	-	26K	-	-
Asset Writedown & Restructuring Costs	-	-	-	-	-
Stock-Based Compensation (CF)	5.23M	5.96M	5.34M	858K	246K
Net Cash From Discontinued Operations	-	-	-	-11.91M	-
Other Operating Activities, Total	-31K	-	-279K	-	-
Change In Accounts Receivable	-	1M	-2.4M	1.37M	-1.32M
Change In Accounts Payable	4.22M	4.14M	-4.3M	611K	8.76K
Change in Unearned Revenues	-	1.15M	1.35M	-	-
Change in Other Net Operating Assets	-649K	-816K	-464K	861K	885K
Cash from Operations	-18.86M	-27.28M	-26.97M	-16.44M	-10.91M
Capital Expenditure	-10.43M	-3.13M	-4.95M	-	-
Other Investing Activities, Total	-	-	-	18.66M	-
Cash from Investing	-10.43M	-3.13M	-4.95M	18.66M	-
Short Term Debt Repaid, Total	-	-	-	-	-
Total Debt Repaid	-	-	-	-	-
Issuance of Common Stock	6.74M	52.56M	202K	1.11M	14.99M
Repurchase of Common Stock	-	-	-	-	-
Other Financing Activities, Total	-	-	-	-	-
Cash from Financing	6.74M	52.56M	202K	1.11M	14.99M
Net Change in Cash	-22.55M	22.14M	-31.72M	3.33M	4.08M
Supplemental Items
Levered Free Cash Flow	-19.43M	-12.98M	-20.92M	-10.14M	-7.13M
Unlevered Free Cash Flow	-19.43M	-12.98M	-20.92M	-10.14M	-7.13M
Change In Net Working Capital	-2.75M	-5.7M	6.28M	1.89M	425K
Net Debt Issued / Repaid	-	-	-	-	-

Fiscal Period: December	2020	2021	2022	2023	2024
Profitability
Return on Assets	-39.26	-43.38	-36.5	-35.36	-35.5
Return on Total Capital	-42.9	-51.7	-45.06	-54.16	-42.62
Return On Equity %	-80.37	-117.42	-94.14	-83.47	-65.81
Return on Common Equity	-80.37	-117.42	-94.14	-83.47	-65.81
Margin Analysis
Gross Profit Margin %	-3.94K	-2.14K	-190	-214.6	-104.33
SG&A Margin	2.24K	1.04K	142.23	225.78	64.35
EBITDA Margin %	-6.08K	-3.01K	-301.29	-356.14	-
EBITA Margin %	-6.19K	-3.18K	-332.23	-440.37	-168.69
EBIT Margin %	-6.19K	-3.18K	-332.23	-440.37	-168.69
Income From Continuing Operations Margin %	-6.15K	-3.37K	-332.06	-424.2	-162.82
Net Income Margin %	-6.15K	-3.37K	-332.06	-248.76	-162.82
Net Avail. For Common Margin %	-6.15K	-3.37K	-332.06	-424.2	-162.82
Normalized Net Income Margin	-3.84K	-1.99K	-205.92	-265.06	-101.29
Levered Free Cash Flow Margin	-4.16K	-1.05K	-232.09	-306.27	-108.14
Unlevered Free Cash Flow Margin	-4.16K	-1.05K	-232.09	-306.27	-108.14
Asset Turnover
Asset Turnover	0.01	0.02	0.18	0.13	0.34
Fixed Assets Turnover	0.04	0.06	0.45	-	-
Short Term Liquidity
Current Ratio	3.81	3.56	2.14	5.57	6.36
Quick Ratio	3.49	3.28	1.82	5.25	6.22
Operating Cash Flow to Current Liabilities	-2.95	-2.11	-3.47	-5.35	-3.15
Average Days Payable Outstanding	38.07	53.05	47.17	36.13	27.54
Long Term Solvency
Total Debt/Equity	44.82	26.98	38.86	-	-
Total Debt / Total Capital	30.95	21.25	27.98	-	-
LT Debt/Equity	43.4	25.57	35.91	-	-
Long-Term Debt / Total Capital	29.97	20.14	25.86	-	-
Total Liabilities / Total Assets	40.05	35.44	43.06	17.95	15.73
EBIT / Interest Expense	-	-	-	-	-
Total Debt / EBITDA	-0.45	-0.34	-0.3	-	-
Net Debt / EBITDA	0.33	0.87	0.17	1.28	-
Total Debt / (EBITDA - Capex)	-0.33	-0.31	-0.25	-	-
Net Debt / (EBITDA - Capex)	0.24	0.8	0.14	1.28	-
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	118.95	166.01	625.9	-5.76	99.06
Gross Profit, 1 Yr. Growth %	46.71	44.2	-35.5	-15.96	-3.22
EBITDA, 1 Yr. Growth %	26.65	31.44	-27.25	-30.64	-
EBITA, 1 Yr. Growth %	28.22	36.67	-24.15	-26.32	-23.75
EBIT, 1 Yr. Growth %	28.22	36.67	-24.15	-26.32	-23.75
Earnings From Cont. Operations, 1 Yr. Growth %	33.97	45.89	-28.53	-28.97	-23.6
Net Income, 1 Yr. Growth %	33.97	45.89	-28.53	-72.48	30.28
Normalized Net Income, 1 Yr. Growth %	33.97	37.5	-24.76	-28.15	-23.93
Diluted EPS Before Extra, 1 Yr. Growth %	29.83	-9.87	-34.52	-32.72	-25.05
Net Property, Plant and Equip., 1 Yr. Growth %	2.33K	4.48	-19.64	-	-
Total Assets, 1 Yr. Growth %	-1.61	49.37	-49.48	-50.24	28.58
Tangible Book Value, 1 Yr. Growth %	-37.97	60.86	-55.44	-28.31	32.06
Common Equity, 1 Yr. Growth %	-37.97	60.86	-55.44	-28.31	32.06
Cash From Operations, 1 Yr. Growth %	3.15	36.16	-1.13	-39.05	-33.64
Capital Expenditures, 1 Yr. Growth %	2.68K	-66.16	57.93	-	-
Levered Free Cash Flow, 1 Yr. Growth %	74.1	-28.88	61.13	-31.34	-29.71
Unlevered Free Cash Flow, 1 Yr. Growth %	74.1	-28.88	61.13	-31.34	-29.71
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	50.53	141.34	339.43	63.3	36.96
Gross Profit, 2 Yr. CAGR %	-61.43	45.45	-3.56	-48.27	-9.81
EBITDA, 2 Yr. CAGR %	-	29.02	-2.21	-43.8	-
EBITA, 2 Yr. CAGR %	-55.85	32.38	1.82	-39.23	-25.05
EBIT, 2 Yr. CAGR %	-55.85	32.38	1.82	-39.23	-25.05
Earnings From Cont. Operations, 2 Yr. CAGR %	-55.95	39.8	2.11	-42.09	-26.34
Net Income, 2 Yr. CAGR %	-55.95	39.8	2.11	-55.65	-40.12
Normalized Net Income, 2 Yr. CAGR %	-55.95	35.72	1.71	-40.36	-26.07
Diluted EPS Before Extra, 2 Yr. CAGR %	-71.94	8.17	-23.36	-46.03	-28.99
Net Property, Plant and Equip., 2 Yr. CAGR %	1.1K	403.83	-8.37	-	-
Total Assets, 2 Yr. CAGR %	-14.33	21.23	-13.13	-49.86	-20.01
Tangible Book Value, 2 Yr. CAGR %	-32.12	-0.11	-15.34	-43.48	-2.7
Common Equity, 2 Yr. CAGR %	-32.12	-0.11	-15.34	-43.48	-2.7
Cash From Operations, 2 Yr. CAGR %	14.13	22.15	16.03	-22.37	-36.4
Capital Expenditures, 2 Yr. CAGR %	740.34	188.96	-26.89	-	-
Levered Free Cash Flow, 2 Yr. CAGR %	-49.21	7.86	7.05	-11.62	-30.53
Unlevered Free Cash Flow, 2 Yr. CAGR %	-49.21	7.86	7.05	-11.62	-30.53
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	36.62	81.99	248.37	92.14	74.44
Gross Profit, 3 Yr. CAGR %	53.73	-40.14	10.91	-27.2	-36.26
EBITDA, 3 Yr. CAGR %	-	-	6.59	-25.4	-
EBITA, 3 Yr. CAGR %	36.01	-35.65	9.95	-20.38	-34.45
EBIT, 3 Yr. CAGR %	36.01	-35.65	9.95	-20.38	-34.45
Earnings From Cont. Operations, 3 Yr. CAGR %	37.75	-34.34	11.78	-21.2	-36.48
Net Income, 3 Yr. CAGR %	37.75	-34.34	11.78	-34.04	-36.48
Normalized Net Income, 3 Yr. CAGR %	35.75	-35.62	11.49	-21.21	-35.32
Diluted EPS Before Extra, 3 Yr. CAGR %	-19.31	-58.6	-8.64	-36.07	-39.79
Net Property, Plant and Equip., 3 Yr. CAGR %	-	431.35	173.24	-	-
Total Assets, 3 Yr. CAGR %	106.5	3.12	-9.45	-27.86	-31.37
Tangible Book Value, 3 Yr. CAGR %	95.53	-9.5	-23.68	-19.9	-25
Common Equity, 3 Yr. CAGR %	95.53	-9.5	-23.68	-19.9	-25
Cash From Operations, 3 Yr. CAGR %	30.74	23.51	13.84	-6.38	-26.32
Capital Expenditures, 3 Yr. CAGR %	-	176.78	136.26	-	-
Levered Free Cash Flow, 3 Yr. CAGR %	61.33	-44.35	23.3	-17.79	-18.12
Unlevered Free Cash Flow, 3 Yr. CAGR %	61.33	-44.35	23.3	-17.79	-18.12
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-	-	118	74.27	98.63
Gross Profit, 5 Yr. CAGR %	-	-	27.57	-43.53	-11.34
EBITA, 5 Yr. CAGR %	36.22	35.98	21.14	-37.11	-13.17
EBIT, 5 Yr. CAGR %	36.22	35.98	21.14	-37.11	-13.17
Earnings From Cont. Operations, 5 Yr. CAGR %	-3.37	76.35	22.2	-37.56	-12.92
Net Income, 5 Yr. CAGR %	-3.37	76.35	22.2	-43.88	-12.92
Normalized Net Income, 5 Yr. CAGR %	-3.35	76.27	20.95	-37.56	-13
Diluted EPS Before Extra, 5 Yr. CAGR %	-42.01	-5.13	-20.96	-54.01	-23.96
Total Assets, 5 Yr. CAGR %	47	53.78	46.05	-22.72	-13.83
Tangible Book Value, 5 Yr. CAGR %	5.06	48.05	39.9	-25.03	-15.89
Common Equity, 5 Yr. CAGR %	5.06	48.05	39.9	-25.03	-15.89
Cash From Operations, 5 Yr. CAGR %	34.13	33.18	26.16	2.57	-9.81
Levered Free Cash Flow, 5 Yr. CAGR %	-4.63	-15.41	35.22	-33.04	-8.58
Unlevered Free Cash Flow, 5 Yr. CAGR %	-4.63	-15.41	35.22	-33.04	-8.58